Biomarkers and assessment of vaccine responses (Q36318008)

13 August 2017

1 reference

title

Biomarkers and assessment of vaccine responses (English)

1 reference

13 August 2017

0 references

Wayne R Hogrefe

1

1 reference

13 August 2017

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10 Suppl 1

1 reference

13 August 2017

page(s)

S50-7

1 reference

Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Development of surrogate markers for oral immunisation against Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Cytokine production patterns and antibody response to measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Cancer vaccines: is the future now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epitopes detect reliably specific CD4(+) T cells in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13547500500216629

10.1080/13547500500216629

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference